Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
treatment group:Traditional Chinese medicine granule preparation
control group:placebo
Sponsors
Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
60 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Define close contacts in accordance with the COVID-19 Prevention and Control Plan (Eighth Edition) issued by the Comprehensive Team of the Joint Prevention and Control Mechanism of The State Council; 2. Aged >= 60 years; 3. Did not participate in clinical studies of other drugs within 1 month before enrollment; 4. Voluntarily accept treatment and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with covid-19; 2. Patients with unclear consciousness, dementia, mental illness or inability to communicate normally; 3. Patients with severe cardiac insufficiency (i.e. cardiac function grade IV), severe liver or kidney diseases, bronchial asthma, COPD, nervous system diseases, tumors, chest malformations or immune deficiency diseases; 4. Patients known to be allergic to any therapeutic drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of COVID-19; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome effect;???? adverse event; | — |
Countries
China
Contacts
Public ContactJin Zhu, Zhang Ziaodan
Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine
Outcome results
None listed